Olema Pharmaceuticals, Inc.OLMANASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-104.51M
↓ 110% below average
Average (6y)
$-49.73M
Historical baseline
Range
High:$-2.18M
Low:$-104.51M
CAGR
+90.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-104.51M | -24.8% |
| 2023 | $-83.73M | -1.6% |
| 2022 | $-82.43M | -57.7% |
| 2021 | $-52.27M | -162.3% |
| 2020 | $-19.92M | -546.6% |
| 2019 | $-3.08M | -41.6% |
| 2018 | $-2.18M | - |